Deletion of thioredoxin‐interacting protein preserves retinal neuronal function by preventing inflammation and vascular injury

Abstract

Targeting TXNIP expression prevented early retinal ganglion cell death, glial activation, retinal inflammation and secondary neuro/microvascular degeneration and preserved retinal function. TXNIP is a promising new therapeutic target for retinal neurodegenerative diseases.